These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809 [TBL] [Abstract][Full Text] [Related]
8. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Payne CM; Holubec H; Bernstein C; Bernstein H; Dvorak K; Green SB; Wilson M; Dall'Agnol M; Dvorakova B; Warneke J; Garewal H Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2066-75. PubMed ID: 16172211 [TBL] [Abstract][Full Text] [Related]
9. Regulation of cytochrome P450 gene expression in the olfactory mucosa. Ling G; Gu J; Genter MB; Zhuo X; Ding X Chem Biol Interact; 2004 Apr; 147(3):247-58. PubMed ID: 15135081 [TBL] [Abstract][Full Text] [Related]
11. Gene regulation. One man's food. Lazar MA Nature; 2000 Oct; 407(6806):852-3. PubMed ID: 11057652 [No Abstract] [Full Text] [Related]
12. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Pool-Zobel BL; Selvaraju V; Sauer J; Kautenburger T; Kiefer J; Richter KK; Soom M; Wölfl S Carcinogenesis; 2005 Jun; 26(6):1064-76. PubMed ID: 15746163 [TBL] [Abstract][Full Text] [Related]
13. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. Brandon EF; Bosch TM; Deenen MJ; Levink R; van der Wal E; van Meerveld JB; Bijl M; Beijnen JH; Schellens JH; Meijerman I Toxicol Appl Pharmacol; 2006 Feb; 211(1):1-10. PubMed ID: 15975613 [TBL] [Abstract][Full Text] [Related]
15. Comparisons of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels. Quinn AM; Penning TM Chem Res Toxicol; 2008 May; 21(5):1086-94. PubMed ID: 18402469 [TBL] [Abstract][Full Text] [Related]
16. RNA expression of cytochrome P450 in breast cancer patients. Vaclavikova R; Hubackova M; Stribrna-Sarmanova J; Kodet R; Mrhalova M; Novotny J; Gut I; Soucek P Anticancer Res; 2007; 27(6C):4443-50. PubMed ID: 18214058 [TBL] [Abstract][Full Text] [Related]
17. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cribb AE; Knight MJ; Dryer D; Guernsey J; Hender K; Tesch M; Saleh TM Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):551-8. PubMed ID: 16537715 [TBL] [Abstract][Full Text] [Related]
18. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver. Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526 [TBL] [Abstract][Full Text] [Related]
19. Probing the world of cytochrome P450 enzymes. Frye RF Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869 [TBL] [Abstract][Full Text] [Related]
20. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions. Lee MD; Ayanoglu E; Gong L Xenobiotica; 2006; 36(10-11):1013-80. PubMed ID: 17118918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]